Chronic Treatment With Qiliqiangxin Ameliorates Aortic Endothelial Cell Dysfunction in Diabetic Rats

Autophagy Protects Against Senescence and Apoptosis via the RAS-Mitochondria in High-Glucose-Induced Endothelial Cells

(2014) Fei Chen et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I

(2013) Francesco Paneni et al.   EUROPEAN HEART JOURNAL

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart Failure

(2013) Xinli Li et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

NOX1 abet mesangial fibrogenesis via iNOS induction in diabetes

(2013) Ling Gao et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF-κB in LPS-stimulated RAW264.7 cells and mouse liver

(2013) Dae Hyun Kim et al.   Journal of Ginseng Research

Prediction of morbidity and mortality in patients with type 2 diabetes

(2013) Brian J. Wells et al.   PeerJ

Reduced Endoglin Activity Limits Cardiac Fibrosis and Improves Survival in Heart Failure

(2012) Navin K. Kapur et al.   CIRCULATION

Targeted Disruption of Inducible Nitric Oxide Synthase Protects Against Aging, S-Nitrosation, and Insulin Resistance in Muscle of Male Mice

(2012) E. R. Ropelle et al.   DIABETES

Endothelial dysfunction in type 2 diabetes

(2012) A. Natali et al.   DIABETOLOGIA

Qiliqiangxin Affects L Type Current in the Normal and Hypertrophied Rat Heart

(2012) Yidong Wei et al.   Evidence-based Complementary and Alternative Medicine

Mending injured endothelium in chronic heart failure: A new target for exercise training

(2012) Emeline M. Van Craenenbroeck et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Endothelial Dysfunction, Arterial Stiffness, and Heart Failure

(2012) Catherine N. Marti et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Qiliqiangxin Improves Cardiac Function in Spontaneously Hypertensive Rats Through the Inhibition of Cardiac Chymase

(2011) W. Liu et al.   AMERICAN JOURNAL OF HYPERTENSION

Qiliqiangxin Inhibits the Development of Cardiac Hypertrophy, Remodeling, and Dysfunction During 4 Weeks of Pressure Overload in Mice

(2011) Yunzeng Zou et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Cardiomyocyte autophagy is regulated by angiotensin II type 1 and type 2 receptors

(2009) Enzo R. Porrello et al.   Autophagy

Qiliqiangxin regulates the balance between tumor necrosis factor-α and interleukin-10 and improves cardiac function in rats with myocardial infarction

(2009) Hong Xiao et al.   CELLULAR IMMUNOLOGY

Angiotensin II Type 2 Receptor Antagonizes Angiotensin II Type 1 Receptor–Mediated Cardiomyocyte Autophagy

(2009) Enzo R. Porrello et al.   HYPERTENSION

Sulfhydryl Angiotensin-Converting Enzyme Inhibitor Promotes Endothelial Cell Survival through Nitric-Oxide Synthase, Fibroblast Growth Factor-2, and Telomerase Cross-Talk

(2009) S. Donnini et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

(2007) N S Kirkby et al.   BRITISH JOURNAL OF PHARMACOLOGY